Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways.
Among the newly discovered amyloid properties, its cytotoxicity plays a key role. Lysozyme is a ubiquitous protein involved in systemic amyloidoses in vivo and forming amyloid under destabilising conditions in vitro. We characterized both oligomers and fibrils of hen lysozyme by atomic force microscopy and demonstrated their dose (5-50 microM) and time-dependent (6-48 h) effect on neuroblastoma SH-SY5Y cell viability. We revealed that fibrils induce a decrease of cell viability after 6 h due to membrane damage shown by inhibition of WST-1 reduction, early lactate dehydrogenase release, and propidium iodide intake; by contrast, oligomers activate caspases after 6 h but cause the cell viability to decline only after 48 h, as shown by fluorescent-labelled annexin V binding to externalized phosphatidylserine, propidium iodide DNA staining, lactate dehydrogenase release, and by typical apoptotic shrinking of cells. We conclude that oligomers induce apoptosis-like cell death, while the fibrils lead to necrosis-like death. As polymorphism is a common property of an amyloid, we demonstrated that it is not a single uniform species but rather a continuum of cross-beta-sheet-containing amyloids that are cytotoxic. An abundance of lysozyme highlights a universal feature of this phenomenon, indicating that amyloid toxicity should be assessed in all clinical applications involving proteinaceous materials.
Gharibyan
Anna L
AL
Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.
Zamotin
Vladimir
V
Yanamandra
Kiran
K
Moskaleva
Olesya S
OS
Margulis
Boris A
BA
Kostanyan
Irina A
IA
Morozova-Roche
Ludmilla A
LA
D000682:Amyloid / Q000302:isolation & purification / Q000494:pharmacology* / Q000648:ultrastructure; D000818:Animals; D017304:Annexin A5 / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D005453:Fluorescence; D057927:Hydrophobic and Hydrophilic Interactions; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D018625:Microscopy, Atomic Force; D009113:Muramidase / Q000302:isolation & purification / Q000494:pharmacology* / Q000648:ultrastructure; D009336:Necrosis; D010084:Oxidation-Reduction / Q000187:drug effects; D020836:Protein Structure, Quaternary; D012995:Solubility / Q000187:drug effects; D013778:Tetrazolium Salts / Q000494:pharmacology
C110656:2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium; D000682:Amyloid; D017304:Annexin A5; D013778:Tetrazolium Salts; D007770:L-Lactate Dehydrogenase; C421864:hen egg lysozyme; D009113:Muramidase; D020169:Caspases